FDA Inspection 1237865 — Silas, Peter E. (MD)
The FDA completed an inspection of Silas, Peter E. (MD) on May 2, 2024 in Syracuse, UT. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 2, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Syracuse, UT (United States)
Additional Details
Clinical Investigator (CI)